Loading publications…
The last 5 uploaded publications
Pharmaceutical development and optimization of azithromycin suppository for paediatric use
Tina Kauss, Alexandra Gaubert, Chantal Boyer, Boubakar B. Ba, Muriel Manse, Stéphane Massip, Jean‐Michel Léger, Fawaz Fawaz, Martine Lembege, Jean‐Michel Boiron, Xavier Lafarge, Niklas Lindegårdh, Sir Nicholas White, Piero Olliaro, Pascal Millet, Karen Gaudin (2012). Pharmaceutical development and optimization of azithromycin suppository for paediatric use. International Journal of Pharmaceutics, 441(1-2), pp. 218-226, DOI: 10.1016/j.ijpharm.2012.11.040.
Article144 days agoDevelopment of rectal self-emulsifying suspension of a moisture-labile water-soluble drug
Tina Kauss, Alexandra Gaubert, Luc Tabaran, Giovanni Tonelli, Thida Phoeung, M. LANGLOIS, Sir Nicholas White, Anthony C. Cartwright, Melba Gomes, Karen Gaudin (2017). Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drug. International Journal of Pharmaceutics, 536(1), pp. 283-291, DOI: 10.1016/j.ijpharm.2017.11.067.
Article144 days agoThe initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
Catherine Lacaze, Tina Kauss, Jean‐René Kiechel, Antonella Caminiti, Fawaz Fawaz, Laurent Terrassin, Sylvie Cuart, L. Grislain, Visweswaran Navaratnam, Bellabes Ghezzoul, Karen Gaudin, Sir Nicholas White, Piero Olliaro, Pascal Millet (2011). The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. Malaria Journal, 10(1), DOI: 10.1186/1475-2875-10-142.
Article144 days agoScreening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment
Tina Kauss, Karen Gaudin, Alexandra Gaubert, Boubakar Ba, Serena Tagliaferri, Fawaz Fawaz, J Fabre, Jean‐Michel Boiron, Xavier Lafarge, Sir Nicholas White, Piero Olliaro, Pascal Millet (2012). Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment. International Journal of Pharmaceutics, 436(1-2), pp. 624-630, DOI: 10.1016/j.ijpharm.2012.07.030.
Article144 days agoPreformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations
Tina Kauss, Mathieu Marchivie, Thida Phoeung, Alexandra Gaubert, Amélie Désiré, Giovanni Tonelli, Chantal Boyer, M. LANGLOIS, Anthony C. Cartwright, Melba Gomes, Sir Nicholas White, Karen Gaudin (2017). Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations. European Journal of Pharmaceutical Sciences, 104, pp. 382-392, DOI: 10.1016/j.ejps.2017.04.010.
Article144 days ago